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Abstract 
 
 Microarray Comparative Genomic Hybridization (arrayCGH) allowed a significant 
advance on the diagnose of unexplained development disorders by detecting genomic 
copy number variations (CNVs) that were previously undetectable by other types of 
cytogenetic technologies. Well characterized genetic syndromes are detected and also 
new genomic disorders and diseases causing CNVs are being discovered through the 
utilization of this technique.  
 The pathogenicity assessment of the CNVs detected by arrayCGH are directly or 
indirectly related with a query of previously recorded and classified CNVs. When a CNV 
that has not been observed before appears, clinicians have to interpret the variant of 
uncertain clinical significance (VOUS), which can be very challenging for them. However, 
sharing classified CNVs between laboratories can be helpful when facing a VOUS in order 
to help its classification as benign or pathogenic. 
 Easily recording, querying and sharing information about CNVs is very important 
for clinicians and laboratories in order to accomplish the right diagnostic for their 
patients. In this work is presented the development of a database, using a LAMP 
technology (Linux, Apache, MySQL and PHP), to store arrayCGH records and of an 
interface that laboratory clinicians can use for querying and management of CNVs. 
  
  
 
v 
 
 
Resumo 
 
 A técnica de Microarray de Hibridização Genómica Comparativa (arrayCGH) 
permitiu um avanço significativo no diagnóstico de doenças de desenvolvimento 
incompreensíveis através da deteção de variações do número de cópia genómicas 
(CNVs) que antes eram indetetáveis por outros tipos de tecnologias citogenéticas. 
Através desta técnica são detetadas síndromes genéticas já identificadas mas também 
novos distúrbios e novas doenças genómicas causadas por CNVs. 
 A avaliação da patogenicidade das CNVs detetadas por arrayCGH está direta ou 
indiretamente relacionada com a consulta de CNVs previamente classificadas e 
arquivadas. Quando é detetada uma CNV anteriormente não observada, os clínicos tem 
de interpretar uma variação de significado clínico incerto (VOUS) o que pode ser muito 
complicado para eles. No entanto, a partilha de CNVs classificadas entre laboratórios 
pode ajudar quando uma variação destas aparece, de modo a poder classificá-la como 
benigna ou patogénica. 
 Guardar, consultar e partilhar informação sobre CNVs de uma forma fácil é muito 
importante para os clínicos e para os laboratórios de modo a que estes possam fazer um 
diagnóstico correto dos seus pacientes. Neste trabalho é apresentado o 
desenvolvimento de uma base de dados, usando a tecnologia LAMP (Linux, Apache, 
MySQL e PHP), para guardar registos de arrayCGH e para dar aos clínicos laboratoriais 
uma interface para consultar e gerir CNVs. 
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1. Introduction 
 
1.1. Motivation 
 
 Microarray Comparative Genomic Hybridization (arrayCGH) allowed a significant 
advance on the diagnose of unexplained development diseases by detecting genomic 
copy number variations (CNVs) that were previously undetectable by other types of 
cytogenetic technologies. Well characterized genetic syndromes are detected and also 
new genomic disorders and diseases causing CNVs are being discovered through the 
utilization of this technique. 
 The pathogenicity assessment of the CNVs detected by arrayCGH are directly or 
indirectly related with a query of previously recorded and classified CNVs. When a CNV 
that has not been observed before appears, clinicians have to interpret the variance of 
uncertain significance (VOUS), which can be very challenging for them. However, sharing 
classified CNVs between laboratories can be helpful when facing a VOUS in order to help 
its classification as benign or pathogenic. 
 At Laboratório de Citogenética e Genómica da Faculdade de Medicina de 
Coimbra, the arrayCGH technique is performed since 2011. From that year until the 
beginning of 2015, the clinicians of this laboratory saved arrayCGH results of their 
patients in spreadsheet files to help in future clinical diagnosis of new patients. Until the 
beginning of 2015, they kept a record of about 4000 arrayCGH results. However, as the 
number of arrayCGH results increased, the laboratory clinicians start to face added 
difficulties to find the results they needed to help in the decision about the pathogenicity 
of a CNV in recent arrayCGH results. This situation prompted them to look into a more 
efficient way to save and query their results. 
 As a solution, the clinicians chose to develop an in-house relational Database 
(DB) to store their results and an application which allows them to feed and query the 
DB and to share their results with others. 
Chapter 1: Introduction 
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1.2. Goals 
 
 The main goal of this project is develop a Database for Array Comparative 
Genomic Hibridization and an application which allows uploading spreadsheets of 
arrayCGH results performed at Laboratório de Citogenética e Genómica da Faculdade de 
Medicina de Coimbra, and also to query about CNVs stored on the database, in order to 
help on daily clinical practice. 
 Another goal is allowing the share of stored results with other clinicians from 
Portugal and also store results from other Portuguese laboratories. 
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2. Background 
 
2.1. The arrayCGH technique 
 
 Microarray comparative genomic hybridization (arrayCGH) is a cytogenomic 
technique used to detect copy number variations (CNV) in chromosomes which are too 
small to be seen down a microscope. It has a higher resolution than G-banded 
karyotyping which has been the standard first-tier test for detection of chromosomal 
alterations for more than 35 years 1. Earlier, the arrayCGH technique allowed resolutions 
larger than 200 Kb, however its resolution level was increasing every year since its first 
appearance2, reaching a resolution of about 1Kb (smaller than the average gene)3. The 
arrayCGH resolution exceed the resolution of G-banded karyotyping (with resolutions 
about 5-10 Mb)3 and is more precise at mapping chromosomal aberrations when 
compared with traditional cytogenetic techniques2. 
 This technique was first developed as a research tool for the investigation of 
genomic alterations in cancer4 and later started to be used as a clinical diagnosis tool for 
patients with an unexplained development delay or multiple congenital abnormalies1, 4. 
 It is based on traditional metaphase CGH technique and it compares a patient 
DNA sample against a control DNA sample. Equal amounts of a patient DNA sample and 
a control DNA sample are labelled with two different fluorescent dyes and are 
competitively hybridized on a microarray. This is spotted with millions of DNA probes 
that have been robotically printed to represent the entire human genome or only a 
specific region. Each probe is spotted with millions of oligonucleotides where the DNA 
samples will hybridize. For regions where there is no genomic differences between the 
patient DNA and the control DNA, equal amounts of each DNA sample will bind to the 
probes. But, if the patient has a gain or a loss of genetic material, there will be a 
difference between the amounts of each DNA sample bound to the probes, and as a 
consequence, there will be different levels of fluorescence.4, 5 
Chapter 2: Background 
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 A computer imaging program evaluates the fluorescence level of each probe in 
the microarray and returns the correspondent logarithmic values of the ratios (log2 
scale). These values carry the information about the proportion of the control DNA 
sample and the patient DNA sample bound to the probes. With this information, 
chromosome regions that have been amplified or deleted, known as CNV, are identified 
on the patient DNA and are interpreted and reported by a clinic laboratory geneticist.4, 
5 
 
Development of a Database for Array Comparative Genomic Hybridization 
5 
 
 
Figure 1 – Schematic representation of array CGH technique. Equal amounts of a patient DNA sample (right) and a 
control DNA sample (left) are labelled with two different fluorescent dyes and are competitively hybridized on a 
microarray. A computer imaging program evaluates the fluorescence level of each probe in the microarray (bottom 
left) and returns the correspondent logarithmic values of the ratios, log2 scale (bottom right). Figure from Bejjani, B., 
and Lisa, S. (2006). Application of Array-Based Comparative Genomic Hybridization to Clinical Diagnostics. Journal of 
Molecular Diagnostics, Vol. 8, Nº. 5. DOI: 10.2353/jmoldx.2006.060029 
 
2.2. The laboratory steps of the arrayCGH technique 
 
 Figure 2 shows an overview of the laboratory workflow which takes normally six 
days.  
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Figure 2 – Laboratory workflow of the arrayCGH technique. 
 
 Briefly, the main points of arrayCGH workflow are : 
1. DNA extraction and quantification: the patient DNA sample can be obtained by 
any type of DNA extraction that yields high molecular DNA suitable for use in 
arrayCGH. The control DNA sample can be taken from blood lymphocytes from 
any karyotypically healthy normal individual. After that, a DNA quantification is 
performed for each sample because different microarray formats require 
different DNA quantities (Table I).5 
 
Table I - Requirement of gDNA Input Amount and Volume per Microarray. Table from: Agilent Oligonucleotide Array-
Based CGH for Genomic DNA Analysis Protocol. Version 7.3. Agilent Technologies, Inc. 5301 Stevens Creek Blvd, Santa 
Clara, CA 95051 USA. March 2014. Manual Part Number G4410-90010. 
 
 
2. Case selection: on this step a patient DNA sample and a control DNA sample are 
grouped by gender. Male patient DNA samples are grouped with male control 
DNA samples and female patient DNA samples are grouped with female DNA 
control samples.2 
 
Day 1
•DNA extraction 
and 
quantification
•Case selection
Day 2
•DNA labelling
•Quantification 
of the labelled 
samples
Day 3
•Hybridization
Day 4
•Washing
•Scanning
Day 5
•Image 
processing
•Quality control 
test
Day 6
•Interpretation 
of the 
arrayCGH result
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3. DNA labelling: the patient DNA sample and the control DNA sample are labelled 
with two different fluorescent dyes. Usually, the patient sample is labelled with 
a red fluorescent dye (Cy5) and the control sample is labelled with a green 
fluorescent dye (Cy3). Later, this step will allow to determine the amount of each 
DNA sample bound to each probe in the microarray.6 
 
4. Quantification of the labelled samples: the two DNA samples will have to 
compete for a spot in the probes of the microarray. So, it is important to have 
equal amounts of labelled DNA samples. Different quantities of labelled DNA 
samples will cause an unbalanced competition. If one of the DNA samples has 
more DNA labelled it will lead to an advantage in the competition for a spot of 
the microarray and the significance of the differences between the patient 
sample and the control sample will be compromised.6 
 
5. Hybridization: the two samples are dropped in the microarray on an oven at 67 
°C. This process breaks the double strand of the DNA samples into single strands. 
The single strands compete to a probe spot which has complementary 
oligonucleotides. The duration of this step depends on the microarray format.7 
 
6. Washing: microarray is washed to remove the DNA which was not bound to any 
probe.5,6 
 
7. Scanning and image processing: microarray is scanned into image files using a 
microarray scanner, and the fluorescence intensities of red and green bound to 
each probe are measured (Figure 3). The resulting ratio of fluorescence 
intensities is proportional to the ratio of the copy numbers of DNA sequences in 
the patient and control genomes, which is converted to a log2 ratio and displayed 
for CNV analysis.2 
Chapter 2: Background 
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Figure 3 - Fluorescence intensities of four microarrays experiments. Figure from: Laboratório de Citogenética e 
Genómica da Faculdade de Medicina de Coimbra. 
 
8. Quality control test: this step is used to assess the relative data quality from a 
set of microarray by performing several tests, such as: verify the alignment of 
the probes positions, the intensity levels of green and red signals, the spread of 
red and green on the microarray and the noise level. In some cases, they can 
indicate potential processing errors that have occurred or suggest that the data 
from particular microarrays might be compromised (Figure 4).7 
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Figure 4 - Scanned images of microarrays with quality defects displayed. On the left and middle, defects resulting from 
large air bubbles during the hybridization process are shown. Poor hybridization is visible as the darker regions, which 
show reduced signal intensities of the underlying targets. On the right, typical defects introduced on washing (seen as 
green fluorescence) are shown. Figure from: Vermeesch, J., et al. (2012). Genome-Wide Arrays: Quality Criteria and 
Platforms to be Used in Routine Diagnostics. WILEY PERIODICALS, INC. DOI: 10.1002/humu.22076 
 
 The last step, the clinical interpretation of an arrayCGH result, requires a more 
detailed explanation for the comprehension of this work and is described on the next 
section. 
 
2.3. The interpretation of an arrayCGH result 
 
 The interpretation of an arrayCGH result needs an understanding of the base-2 
logarithmic values obtained in the fluorescence analysis of the microarray probes. Each 
logarithmic value corresponds to a probe and, each probe represents a specific region 
of the human genome where one fraction of patient DNA and one fraction of control 
DNA are bound. By the inverse of the logarithmic the proportions of each DNA sample 
can be estimated5,8:  
Chapter 2: Background 
10 
 
 
𝑙𝑜𝑔2(𝑟𝑎𝑡𝑖𝑜) = 𝑦  (1.1) 
𝑟𝑎𝑡𝑖𝑜 =  2𝑦 , 
For a given probe, the y is one logarithmic value in the log2 scale, obtained from image 
processing, and the ratio is the proportion of each DNA sample present in the probe. 
 For probes where y is smaller than zero there is a loss of genetic material. In 
these cases, less quantity of patient DNA sample was present in the probes when 
comparing to the control DNA sample. A gain of genetic material occurs when the y is 
greater than zero, which means that exists more quantity of patient DNA sample than 
the control DNA sample bound to the probe. If y is zero, there is no genomic differences 
for that region and the same quantity of each DNA sample were hybridized in the 
probe.5,8 
 
 
Figure 5 – Genomic imbalances via log2 ratio. The figure displays a typical plot of array CGH data, with probes plotted 
by genomic position on the x-axis and by the normalised log2 R signal intensity ratios on the y-axis. Figure adapted 
from: Brady, P. and Vermeesch, J. (2012) Genomic microarrays: a technology overview. John Wiley & Sons, Ltd. DOI: 
10.1002/pd.2933 
 
 For clinical reports only cases with a minimum of three consecutive probes with 
gains or three consecutive probes with losses are reported. Here, the proportions of 
patient and control DNA samples are calculated by equation (1.1) but y is the mean of 
the logarithmic values of the probes which reported the alteration. 
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 A reported alteration is known as a copy number variation (CNV), which 
corresponds to a region of the genome, where alterations may range from about one 
kilobase to several megabases, that have been deleted or amplified on a certain 
chromosome.4,5 A set of CNVs is the result of an arrayCGH and the clinic interpretation 
is an interpretation of all CNVs in the set. There are two main steps when interpreting a 
CNV: 
 
 The first is to analyse the “CNV ratio”, meaning if the CNV is a deletion or an 
amplification in a certain chromosome. 
 Then, it is necessary to determine if the CNV has an impact on the patient life, in 
other words, if the CNV is benign or pathogenic. 
 
 An example of a possible arrayCGH result and the first step in its interpretation 
is shown below. 
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Table II - Example of an arrayCGH result. Each line is a CNV and each CNV is characterized by the chromosome where 
the variation appears, a cytoband which is a pattern capable of identifying a location in a chromosome, a start and a 
stop reference, a size of the alteration, the number of probes which reported the alterations and a log2(ratio), a mean 
of the all log2(ratio) registered by all the proves involved in a certain CNV. 
Chromosome Cytoband Start (Kb) Stop (Kb) Size 
(Kb) 
Probes log2(ratio) 
5 p15.33 722994 820565 97572 4 -1.1005 
6 p25.3 255150 362431 107282 9 0.5587 
 
 Determine a “CNV ratio” only requires the application of the log2 inverse (1.1): 
𝐶ℎ𝑟𝑜𝑚𝑜𝑠𝑜𝑚𝑒 5:  𝑟𝑎𝑡𝑖𝑜 =  2−1.1005  ≈ 0,5 =  
1
2
 
𝐶ℎ𝑟𝑜𝑚𝑜𝑠𝑜𝑚𝑒 6:  𝑟𝑎𝑡𝑖𝑜 =  20.5587  ≈ 1,5 =  
3
2
 
 
 The first CNV of the Table II has a ratio of 1/2 which means the control DNA 
sample has 2 copies of that region for each copy of the patient DNA sample. One portion 
of this region is missing on the patient DNA so the patient has one deletion of that region 
when compared with the control DNA sample. The second CNV of the Table II has a ratio 
of 3/2. Here the patient DNA sample has three copies of that region but the control only 
has two copies. In this case the patient shows one duplication of that region. 
 The first step of the interpretation of an arrayCGH result is accomplished but 
what is the impact of the regions that are deleted or amplified in the patient life? Are 
they really pathogenic or are they harmless? 
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2.4. The importance of databases in the interpretation of a CNV 
 
 After determining a “CNV ratio”, the clinicians need to decide about the 
pathogenicity of a CNV. On Table III the main criteria of how to assess the pathogenicity 
of a CNV are presented. 
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Table III - Assessment of Pathogenicity of a CNV. Table from: Miller, D., et al. (2010). Consensus Statement: 
Chromosomal Microarray is a First-Tier Clinical Diagnostic Test for Individuals with Development Disabilities or 
Congenital Anomalies. The American Journal of Human Genetics. ISSN: 86, 749-764. 
Primary Criteria Pathogenic Benign 
1a. Identical CNV inherited from a healthy parent a  X 
1b. Expanded or altered CNV inherited from a parent X  
1c. Identical CNV inherited from an affected parent X  
2a. Similar to a CNV in a healthy relative  X 
2b. Similar to a CNV in an affected relative X  
3. CNV is completely contained within genomic imbalance 
defined by a high-resolution technology in a CNV database 
of healthy individuals 
 X 
4. CNV overlaps a genomic imbalance defined by a high-
resolution technology in a CNV database for patients with 
development delay or congenital anomalies 
X  
5. CNV overlaps genomic coordinates for a known genomic-
imbalance syndrome (i.e., previously published or well-
recognized deletion or duplication syndrome) 
X  
6. CNV contains morbid OMIM genes b X  
7a. CNV is gene rich X  
7b. CNV is gene poor  X 
General Findings c   
1a. CNV is a deletion X  
1b. CNV is a homozygous deletion X  
2a. CNV is a duplication (no known dosage-sensitive genes)  X 
2b. CNV is an amplification (greater than 1 copy gain) X  
3. CNV is devoid of known regulatory elements  X 
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Note: aAn inherited deletion from an unaffected parent could harbour an OMIM (Online 
Mendelian Inheritance in Man, an online catalogue of Human Genes and Genetic Disorders ) 
morbid gene that is recessive and could be pathogenic in conjugation with a point mutation on 
the trans allele inherited from other parent. bCNV should produce the same type of mutation 
that is known to cause the OMIM  disease and the phenotype produced should be that expected 
for the OMIM disease. cExceptions to each case have been seen 
 
 As shown in Table III, the majority of criteria are directly or indirectly related with 
a query of previously recorded CNVs, and this query is often performed on data 
contained in a database. When clinicians make a query for a certain CNV and find a large 
number of matches, the CNV assessment of pathogenicity will be more reliable and 
more accurate.1 
 Sometimes, clinicians get a CNV matching result with a poor number of matches 
or even none when querying databases about a certain CNV. This situation is always a 
challenge for clinicians because they have to interpret variants of uncertain clinical 
significance (VOUS). In this situation, the assessment of pathogenicity sometimes is not 
possible and when it is possible it will be a less reliable and less accurate decision than 
one with a large number of matches. This problem can be addressed through an 
increased data sharing among laboratories and clinicians, and a database will be a good 
solution for registering and sharing information.1 
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2.4.1. Interpretation of CNV at Laboratório de Citogenética e Genómica da Faculdade de 
Medicina de Coimbra 
 
 Table IV describes the CNV classification used at Laboratório de Citogenética e 
Genómica da Faculdade de Medicina de Coimbra. 
 
Table IV – CNV classification used at Laboratório de Citogenética e Genómica da Faculdade de Medicina de Coimbra. 
Class Description 
I 
Deletion or duplication in a region associated with a microdeletion or microduplication 
syndrome. 
II 
Deletions or duplications that are not described in the DGV until to date and involve known 
coding genes. 
IIIA 
Deletions or duplications that, until to date, are reported in low frequency in the DGV or 
are not fully overlapping with those described in DGV. 
IIIB 
Deletions or duplications that, until to date , are reported in low frequency in the DGV or 
are not fully overlapping with those described in DGV, not involving known coding genes. 
IV Deletions or duplications reported in normal subjects in DGV. 
 
DGV - Database of Genomic Variants (http://projects.tcag.ca/variation/) 
 
2.5. Management of arrayCGH results at Laboratório de Citogenética e Genómica da 
Faculdade de Medicina de Coimbra 
 
 The arrayCGH technique is performed at Laboratório de Citogenética e Genómica 
da Faculdade de Medicina de Coimbra since 2011. From that year until the beginning of 
2015, the clinicians of this laboratory saved the arrayCGH results of their patients in 
spreadsheet files for to help in future clinical diagnosis of new patients. Until the 
beginning of 2015, they kept a record of about 4000 arrayCGH results. 
 However, as the number of arrayCGH results increased, the clinicians start to 
face added difficulties to find the results they needed to help in the decision about the 
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pathogenicity of a CNV in recent arrayCGH results. This situation prompted them to look 
into a more efficient way to save and query their results. 
 As a solution, the clinicians chose to develop an in-house relational Database 
(DB) to store their results and an application which allows them to feed and query the 
DB and to share their results with others. The next sections are the report of the 
development of this solution. 
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3. Software Development 
 
3.1 Software Requirements 
 
 The first step of a software development starts with a request from the 
researchers. Normally it is a small statement where some global goals are pointed out9. 
The original request for the software was: 
 Develop and implement a relational database which should contain arrayCGH 
results from patients with cognitive deficit, and also to allow a set of queries 
defined by the laboratory clinicians in a way that can answer to questions or 
hypotheses related with new arrayCGH results. 
 
 This information needs to be analysed in order to break out some requirements 
from what the researchers are asking for. A requirement is a single task that the 
software has to do9. Figure 6 is a set of requirements which can be written with the 
information from the first request. 
 
 
Figure 6 – Requirements extracted from the researchers first request. 
 
 These requirements give some information about some software functionalities. 
However, only with this information, there are a lot of gaps in the understanding of what 
the software is supposed to do. It is necessary to talk with the researchers in order to 
Store arrayCGH results
•The database will have 
to store arrayCGH 
results.
Allow queries about 
arrayCGH results 
•A user will be able to 
perform queries about 
arrayCGH results stored 
on the database.
Show query results
•A user will have to get an 
answer to a query in a 
way that he is able to 
interpret a new 
arrayCGH result. 
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get more details about the requirements and also to find out about additional 
requirements the researchers did not express in the first request. Before start coding a 
software, it is necessary for the researchers to think about everything they want the 
software to realise. There are a lot of techniques which can help accomplish that goal 
such as brainstorming, role playing and observation. These techniques were used 
several times, through an iterative process, in order to better shape the requirements 
to the researchers ideas and to improve or add new functionalities that they were not 
conscious about in the first request of the project. In the end of requirements gathering, 
they must be researcher-oriented. In other words, a requirement should be written from 
the researcher’s perspective, describing what the software is going to do for them. This 
is known as user stories. Both the programmer and the researchers should understand 
the meaning of the user stories. In that way, both will be capable to ask about any 
requirement and communicate with each other at any time of the software 
development.9 A set of researcher-oriented requirements developed for this work are 
presented next and they are grouped by general, researcher, administrator and super 
administrator requirements. 
 
3.1.1. General requirements 
 
 
 
Add a new user
•A new user will be 
able to sign up.
Log in
•An approved user will 
be able to log in.
Log out
•A logged in user will 
be able to log out.
Look for a CNV match
•A user will be able to 
search for a CNV 
match by giving a 
localization or by 
specifying a gene 
name.
Show CNV match
•A user will be able to 
see a bar graph which 
represents the CNVs 
that match his search.
View a clinic case of a 
CNV
•A user will be able to 
view any clinic case of 
a CNV that appeared 
on a CNV match.
Look for a CNV match 
in other DB
•A user will be able to 
look for a CNV match  
in the DB of UCSC, of 
any CNV in a recorded 
arrayCGH result.
Look for a gene 
information
•A user will be able to 
look for information 
about any gene 
contained on a 
arrayCGH result in the 
DB of GeneCards.
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(Legend: DB – Database; UCSC – University of Carolina, Santa Cruz, genome browser at https://genome.ucsc.edu/; 
GeneCards – Human Gene Database at http://www.genecards.org/; UI – User Interface) 
 
3.1.2. Researcher requirements 
 
 
 
 
3.1.3. Administrator requirements 
 
 
Allow diferent kind of 
users
• A user should be one 
of those kinds: 
Researcher, 
Administrator or 
Super Administrator
Show a User Interface
•Show a UI which 
allows users to access 
the software 
funcionalities 
according to their 
kind.
Add a new clinic case
•A researcher will be 
able to upload a 
spreadsheet with the 
information about an 
arrayCGH result.
Show clinic cases
•A researcher will be 
able to see all 
arrayCGH results 
added by him.
Edit a clinic case
•A researcher will be 
able to update any 
information about any 
arrayCGH result 
added by him.
Remove a clinic case
•A researcher will be 
able to remove any 
clinic case added by 
him.
View a Clinic Case
• A user will be able to 
see any arrayCGH 
result added by him.
Show users
•An administrator will 
be able to see all 
information about all 
researchers from his 
laboratory.
Change a user state
•An administrator will 
be able to block or 
approve the acess to 
the software of any 
researcher from his 
laboratory.
Remove a user
•An administrator will 
be able to remove a 
researcher from his 
laboratory.
Search for a user
•An administrator will 
be able to search for a 
researcher from his 
laboratory by the 
researcher name.
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3.1.4. Super Administrator Requirements 
 
 
 
 
Show clinic cases
•An administrator will 
be able to see the 
information about all 
arrayCGH results 
linked to his 
laboratory.
Change a clinic case 
state
•An administrator will 
be able to change the 
visibility state of a 
clinic case linked to 
his laboratory.
View a clinic case
•An administrator will 
be able to see all 
information of any 
clinic case linked to 
his laboratory.
Search a clinic case
•An administrator will 
be able to search for 
any clinic case linked 
to his laboratory by its 
name.
Remove a clinic case
•An administrator will 
be able to remove any 
clinic case linked to 
his laboratory
Show laboratories
•A Super Administrator 
will be able to see the 
information about all 
laboratories.
Edit laboratory
•A Super Administrator 
will be able to update 
all information about 
a laboratory.
Add a new laboratory
•A Super Administrator 
will be able to add a 
new laboratory to the 
DB.
Remove a laboratory
•A Super Administrator 
will be able to remove 
a laboratory.
Search for a laboratory
•A Super Administrator 
will be able to search 
for a laboratory by its 
laboratory name.
Show users
•A Super Administrator 
will be able to see all 
information about all 
researchers and 
administrators.
Change a user state
•A Super Administrator 
will be able to block or 
approve the acess to 
the software of any 
researcher or 
administrator.
Remove a user
•A Super Administrator 
will be able to remove 
a researcher or an 
adminstrator.
Search for a user
•A Super Administrator 
will be able to search 
for a researcher or an 
administrator by his 
name.
Show clinic cases
•A Super Administrator 
will be able to see the 
information about all 
arrayCGH results.
Change a clinic case 
state
•A Super Administrator 
will be able to change 
the visibility state of 
any clinic case.
View a clinic case
•A Super Administrator 
will be able to see all 
information of any 
clinic case.
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3.2. Software Design 
 
 After knowing the software requirements the design process begins, which will 
help a programmer to plan and structure the researcher needs and, later on, in software 
coding and implementation. Three design processes were used in the development of 
this work: a Use Case Diagram (UCD), an Entity-Relationship Model (ERM) and a 
Relational Model (RM). The first one allows to set the system dynamic behaviour. The 
second diagram defines the conceptual view of a DB. The RM is a mapped relational 
schema based on the ERM and is a key diagram when setting up a DB. 
 
3.2.1. Use Case Diagrams (UCD) 
 
 To model a system it is important to know its dynamic behaviour, the evolution 
of the system when it is running. A dynamic behaviour is made of interactions between 
the system and the users or other external systems. UCD can help to model these 
interactions and to map the system requirements.10 
 A UCD is made of actors, use cases and their relationships, in order to model a 
system. Normally, an actor represents a human user, a use case represents some 
functionality of the system and a relationship is an action between actors and use 
cases.10 
 So, to model a system, several UCD are used. The Figures 7, 8 and 9 represent 
simplified UCD of Researcher, Administrator and Super Administrator in this work. 
 
Remove a clinic case
•A Super Administrator 
will be able to remove 
any clinic case.
Search a clinic case
•A Super Administrator 
will be able to search 
for any clinic case by 
its name.
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Figure 7 – Use Case Diagram of a Researcher. 
 
 
Figure 8 – Use Case Diagram of an Administrator. 
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Figure 9 – Use Case Diagram of a Super Administrator. 
 
Notes about UCD: 
 
 A use case is a situation where a system is used to fulfil one or more of the 
researcher-oriented requirements and it captures a piece of functionality that the 
system provides. Use cases describe the system’s requirements strictly from the outside 
and they specify the value/service that the system delivers to the users. 
 After capturing an initial set of actors that interact with the system it is possible 
to start assembling relationships between the actors and the requirements. The purpose 
of use case relationships is to provide the designers of the system with some 
architectural guidance in order to help them break down the system requirements into 
manageable pieces. 
 Figures 7, 8 and 9 only show relationships of the include type. The include 
relationship declares that the use case at the head of the dotted arrow completely 
follows all the steps from the use case being included. The use cases have the name of 
the requirements and they are specified in the Software Requirements, which could help 
with the UCD interpretation. The use case for the requirement “Add a new user” is not 
represented by a UCD, but essentially, a new user will sign up by filling a form with some 
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basic information and by choosing a role (Researcher or Administrator), a laboratory and 
a username and a password in order to log in after being approved.10 
 
3.2.2. Entity-Relationship Model (ERM) and Relational Model (RM) 
 
 An ERM defines the conceptual view of a DB and usually is made of entities, 
attributes and relationships. An entity is a real world object which is defined by a set of 
properties, the attributes. Attributes store some kind of information about an entity. 
Between entities occur relationships, which are a description about an interaction 
between two entities. Figure 10 shows a representation of the ERM model developed 
for this work.11 
 
 
Figure 10 - Entity-Relationship Model. 
 
Notes about ERM: 
 
 The ERM has five entities: “laboratory”, “user”, “clinic case”, “cnv” and “gene”, 
each one with their attributes. But what is the difference between entities and attributes 
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and why they are linked like that? It is not easy to distinguish their roles in database 
modelling, but, briefly, entities should contain descriptive information and attributes 
should be linked to the entities they most directly describe. If there is descriptive 
information about a data element, the data element should be classified as an entity. If 
a data element requires only an identifier and does not have relationships, it should be 
classified as an attribute. With “user”, for example, there are some descriptive 
information such as “first name” and “email”, then “user” should be an entity. If the first 
name and the last name are needed to identify a user, then “first name” and “last name” 
should be classified as attributes associated with the “user” entity. 
 The relations between two entities can be described by its connectivity and its 
existence. Connectivity defines the relation degree between two entities. In other 
words, it defines how many records of a certain entity are allowed to relate with other 
entity records. The connectivity between two entities can be one of the following:11, 12 
 
 One to one (1:1): a record in entity A can have exactly one matching record on 
entity B, and a record in entity B only can have one matching record in entity A 
too. 
 One to many (1:N): a record in entity A can have many matching records in entity 
B, but a record in entity B only can match one record in entity A. 
 Many to Many (N:N): a record in entity A can have many matching records in 
entity B and a record in entity B can have many matching records in entity A, too. 
 
 Existence defines the obligation of a relationship of an entity record to another 
entity record, and it can be: 
 
 Mandatory: If entity A has mandatory existence in entity B, all entity A records 
have to be references in records in entity B. 
 Optional: If entity A has optional existence in entity B, there could exist records 
of entity A which have no references on entity B records. 
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ERM Relationships: 
 
 Laboratory - User: 
 Connectivity 1:N: One laboratory record can have many user records. One user 
record only can match exactly one laboratory record. 
 Existence: One laboratory record can have no reference to a user record 
(optional). One user record always have to be one reference to a laboratory record 
(mandatory). 
 User – Clinic Case: 
 Connectivity 1:N: One user record can have many clinic cases records. One clinic 
case record can have only one user record. 
 Existence: One user record can have no reference to a clinic case record 
(optional). One clinic case record always have to be one reference to a user record 
(mandatory). 
 Clinic Case - CNV: 
 Connectivity 1:N: One clinic case record can have many CNV records. One CNV 
record can have only one clinic case record. 
 Existence: One clinic case record have to be always a reference to a CNV record 
(mandatory). One CNV record always have to be a reference to one clinic case record 
(mandatory). 
 CNV – Gene: 
 Connectivity N:N: One CNV record can have many genes records. One gene 
record can have many CNV records. 
 Existence: One CNV record can have no reference to a gene record (optional). 
One gene record can have no reference to a CNV record (optional). 
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 After setting up an ERM it is easier to develop an RM. ERM entities became RM 
tables, ERM entity’s attributes become RM columns (fields) of tables with their 
respective data types. ERM relationships help at mapping interactions between the 
tables of an RM.11 
 
 
Figure 11 - Relational Model. 
 
Notes about RM: 
 
 The connectivity and the existence describe the relation between two tables in 
the same way as in ERM, but those two concepts are not enough to model a database. 
An important thing to address when setting up a database is how the data contained in 
tables will be used. The goal is to use the columns in a way that makes getting the 
information out of it easy. It is simpler to accomplish that goal when tables are 
normalized, and databases with normal tables have huge benefits:13 
 Normal tables won’t have duplicate data, which will reduce the size of the 
database. 
 With less data to search through, queries will be faster. 
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 In order to be normal, a table has to follow some rules: 
 
1. First Normal Form (1NF): 
 
 Each row of data must contain atomic data: small pieces of data that 
cannot or should not be divided. In other words, a column with atomic 
data cannot have several values of the same data type in that column and 
a table with atomic data cannot have multiple columns with the same 
data type. Figures 12 and 13 show two examples where this rule is 
violated: 
 
 
Figure 12 – Example: A table with non-atomic data where several values of same data type are allowed in genes 
column. This table makes queries about genes much harder. 
 
 
Figure 13 – Example: A table with non-atomic data where multiple columns with same data type are allowed. This 
table makes queries about users from a laboratory more difficult. 
 
 Each row of data must have a unique identifier, known as a Primary Key 
(PK): a primary key is a column of a table that makes each record unique. 
A PK cannot be NULL, a value must be given when the record is inserted, 
must be compact and its value cannot be changed. Figure 14 shows an 
example of a table that follows this rule: 
 
Chromosome Start (pb) Stop (pb) Genes
2 12314 423544 ABCA12, CACNB4, DCTN1
X 33454 52343 EMD, DCX, FMR1
Table: CNV
Laboratory Name user1 user2 user3
GeneticLab Maria João Raquel
CitoLab Sara Rui Pedro
Table: Laboratory
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Figure 14 – Example: A table where the ID is the PK. 
 
 When a table has non-atomic columns they need to be moved into new tables 
and the new tables have to be designed in order to obey to 1NF. If those tables have 
records that can be related to the records of the table from where they are moved (the 
parent table), they will need a reference to the parent table. This reference is known as 
Foreign Key (FK). A FK is a column in a table that references the PK of another table. A 
FK is also a table constraint because a FK can only take values that exist in the table 
where the key came from, the parent table, which is known by referential integrity. 
Figure 15 illustrates an example about the utility of a FK. 
 
 
Figure 15 – Example: PK and FK. The User ID on the Clinic Case table is a foreign key because it references a primary 
key from User table. This allows to link clinic cases to researchers from the user table. 
 
 On the ERM a many-to-many connectivity happens between “cnv” entity and 
“gene” entity. On ER model many-to-many connectivities cannot happen because it 
ends up with duplicate data on one of the linked tables which breaks the 1NF. There is 
no good reason to violate the 1NF, and many good reasons not to. One of the most 
important is that it takes a much larger time when querying tables with all the repeated 
data. Another one is to preserve data integrity on delete and update processes. So, to 
solve this issue, a junction table “cnv_gene” is created between the tables “cnv” and 
“gene”. A junction table holds a PK from each table, which allows to relate records 
between the tables. 
 
ID Chromosome Start (pb) Stop (pb)
1 2 12314 423544
2 X 33454 52343
Table: CNV
User ID (PK) First Name Last Name Role Clinic Case ID (PK) User ID (FK) Case Name
3 Ana Correia Administrator 1 5 D233M
4 Tiago Amorim Researcher 2 4 D456M
5 Isabel Silva Researcher 3 5 D245F
Table: User Table: Clinic Case
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3.3. Server: LAMP technology 
 
 Now as the software requirements and the software design are defined, it is 
necessary to set up a system capable of implementing what was projected, a system 
capable of analysing requests, storing information and delivering responses according 
to the requests. A system with these requirements is known as a Server. There are a lot 
of solutions to implement a server; in this work a server based on LAMP technology was 
the chosen option.14 
 LAMP, which stands for Linux, Apache, MySQL and PHP, is a robust set of 
software that works well as a system that has a proven track record of being efficient, 
secure and always on the leading edge of the Internet technology. Also, the LAMP 
solution has the advantage of being free and fast. Each component of LAMP exhibits 
benchmarks that far exceed those of their open source competitors. The Linux/Apache 
combination is capable of serving more pages to its users than other commercial or open 
source solutions. MySQL is the fastest open source database available and is utilized by 
several well-known companies (http://www.mysql.com/customers/). PHP is a very solid 
server-side scripting language.14 
 The major advantages of LAMP were already presented, but their elements need 
a brief explanation in order to understand their importance on LAMP technology. After 
this, the hardware and the software versions used to develop this work are presented.14 
 
3.3.1. Linux Operating System 
 
 Linux is an operating system that runs applications. It is specifically noted for its 
speed, minimal hardware requirements, security and remote administration capability. 
It is a fully featured operating system that does not cost anything to use.14 
 The core of the Linux operating system (the kernel) is under GNU General Public 
License (GPL). The reason Linux is under GPL is simple: people are authorized to make 
modifications of the software, and in turn, release their versions to the public, as long 
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as they release the source code along with it; this allows other people to use and modify 
the work that others have done. GPL it’s a “remember your roots” type of license, which 
allows this open source to continuously evolve.14 
 
3.3.2. Apache Web Server 
 
 Apache is an open source web server solution packed with features, extremely 
fast, and works well with the Linux operating systems. With the Apache Web server it is 
possible to create virtual hosts that allow to run multiple web sites on a single server. 14 
 Apache is a well-known web server solution and is currently the most used 
number web server system worldwide according to Netcraft surveys 
(http://news.netcraft.com/archives/category/web-server-survey.html). 
 
3.3.3. MySQL Database Server 
 
 MySQL is a powerful, robust database manager that enables to store and retrieve 
data with a script language, such as PHP. Using a database is important for creating 
dynamic sites, being able to use a single page of code to deliver different information 
based on a user’s interaction. This would be impossible without the use of a database 
and a scripting language, such as PHP, to manipulate data. 14 
 
3.3.4. PHP Scripting Language 
 
 PHP is a recursive acronym that stands for: Hypertext Preprocessor. It is used for 
Web Development and can be embedded into HTML. It is a simple scripting language 
that enhances a website by allowing interactions with the users.14 
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3.4. Materials 
 
3.4.1. Software versions and hardware 
 
 In this work, the following software versions have been used: 
 Ubuntu 14.04 LTS (Ubuntu is an operating system based on Linux) 
 Apache 2.4.7 
 MySQL 5.5.41 
 PHP 5.5.9 
 
 The hardware has the following specifications: 
 Processor: 2x Intel(R) Pentium(R) 4 CPU 3.20GHz 
 Memory: 1024MB 
 Hard Disk: ATA ST3808110AS (80 GB) 
 
3.4.2. Characterization of arrayCGH results provided for the development of arrayCGH DB 
 
 In order to develop this project, the researchers of Laboratório de Citogenética e 
Genómica da Faculdade de Medicina de Coimbra provided a set of arrayCGH results, 
which they considered representative for the majority of arrayCGH results they have 
stored on spreadsheets since 2011. The set given, contained results from 2013, 2014 
and 2015, and has two types of formats: “Tabela Classes”, a handmade report which is 
delivered to clinicians, and “IntervalBasedReport”, a report exported by CytoGenomics, 
a software for CNV analyses. On Table V are characterized the data contained in 
arrayCHG results for those two format types. 
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Table V – Characterization of arrayCGH results for “IntervalBasedReport” and “Tabela Classes” formats. 
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4. Security 
 
 All data is stored on a relational database and the accesses are regulated by user-
level permissions. Users are allowed to share and manage their own data with different 
users/laboratories. In order to guarantee data integrity and data security, all options 
available for a registered and approved user are only accessible after log in. Clinic Case 
anonymity is ensured as there is no storage of personal information, such as patient 
names. Clinic Cases identification relies on laboratory Clinic Case identification. 
 
4.1. User accesses 
 
 Any given Researcher is only able to access the data stored after an approved 
registration by a high level user, a Super Administrator or an Administrator from the 
same laboratory as the Researcher. A registration of an Administrator only can be 
approved by a Super Administrator. After that, the access can be denied at any time, a 
Super Administrator can block any user, and an Administrator can only block their 
laboratory Researchers. 
 For the user passwords is used a MySQL function that provides a one way 
encryption. This means that it is not possible to decrypt them and it adds an additional 
degree of security for this type of data. However, this does not mean that it is not 
possible to discover the real passwords through brute force attacks, but it makes it more 
difficult. 
 A Super Administrator is able to remove any low level user. An Administrator can 
only remove Researchers from its own laboratory. 
 When a user asks for some content on the server, an authorization process 
verifies if the user has permission to access the content he is asking for, thanks to session 
and cookies variables set up on user log in. 
 Log Out will clear the session and cookies variables. 
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4.2. Clinic Case management and access 
 
 An approved Researcher is able to upload Clinic Cases that report CNVs. All the 
data upload process is verified, and wrong Clinic Case formats or unexpected data are 
rejected, thanks to a validation process. 
 All uploaded Clinic Cases have their state set to hidden, which means that only 
users from the same laboratory as the Researcher that had made the upload can access 
the uploaded information. A Researcher can edit some information of Clinic Cases linked 
to him, such as Clinic Case comments, Clinic Case Gender, CNV class, CNV chromosome, 
CNV genes, CNV inheritance, etc., in order to provide more details about the case or to 
correct some information that was wrong. A Researcher can also remove their Clinic 
Cases. 
 Administrators can change the state, to hidden or to public, and remove Clinic 
Cases which are linked to their laboratory. 
 Super-Administrators can change the state, to hidden or to public, remove and 
view all Clinic Cases. 
 
4.3. Data Removal 
 
 A Super Administrator is able to remove Laboratories and Users. Administrators 
are able to remove Researchers and Clinic Cases from their Laboratories. Researchers 
can only remove their Clinic Cases. 
 Deletes are on cascade, which means that if a Super Administrator decides to 
remove a laboratory he will remove all the data linked to the laboratory, such as Users, 
Clinic Cases and CNVs. This is crucial to safeguard the data referential integrity and will 
prevent errors related to this subject. This is an ultimate option to guarantee the 
database robustness. Before proceeding to a data removal, alternatives like blocking a 
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user or hiding a Clinic Case should be considered. Anyway, before a data removal the 
user will be informed of what he will remove and if he is sure about that, he will be able 
to confirm the process and the data will be removed. 
 
4.4. SQL injection 
 
 Some precautions were taken in order to avoid SQL injection. Data sent by users 
are not used directly when building queries. Instead, data validation processes are used 
through PHP functions and PHP MySQL functions in order to inhibit this kind of database 
attacks.15 
 
4.5. Data Backup 
 
 The solution developed relies on MySQL and stores its data in a MySQL database, 
so a database backup will allow restore all information stored in case of any disaster, 
such as manual mistake, software errors, hardware errors, server compromise, etc. It 
was used mysqldump, a command to dump the database 
(dev.mysql.com/doc/refman/5.1/en/mysqldump.html) written on a file bash script 
which is ran every day through cron, a system daemon used to execute desired tasks (in 
the background) at designated times (help.ubuntu.com/community/CronHowto). 
 
4.6. Ubuntu Security 
 
 Ubuntu is an open source software that is potentially vulnerable until patches 
and updates become available. The Ubuntu security can be secured by a set of 
measures, such as updating the system and by configuring the firewall.16 
 Staying up to date is one of the ways to keep a system secure. There are new 
patches and fixes for Ubuntu frequently. The open source community is constantly 
trying to find exploits and bugs in its software so that they can release patches and make 
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the environment as secure as possible.16 There are some commands to effectively 
update the Ubuntu system: 
 
1. apt-get update, used to re-synchronize the package index files from their 
sources. The indexes of available packages are fetched from the location(s) 
specified in /etc/apt/sources.list. It does not install new versions of software. An 
update should be always performed before an upgrade. 
2. apt-get upgrade, used to install the newest versions of all packages currently 
installed on the system from the sources enumerated in /etc/apt/sources.list. 
Packages currently installed with new versions available are retrieved and 
upgraded; under no circumstances are currently installed packages removed, nor 
are packages that are not already installed retrieved and installed. New versions 
of currently installed packages that cannot be upgraded without changing the 
install status of another package will be left at their current version. 
3. apt-get dist-upgrade, in addition to performing the function of upgrade, this 
option also intelligently handles changing dependencies with new versions of 
packages; apt-get has a "smart" conflict resolution system, and it will attempt to 
upgrade the most important packages at the expense of less important ones, if 
necessary. The /etc/apt/sources.list file contains a list of locations from which to 
retrieve desired package files. 
 
 Configuration of the firewall is another step that should be done to maintain the 
system security. This system belongs to a set of systems with a shared firewall set up by 
the informatics maintenance of the Laboratório de Citogenética e Genómica da 
Faculdade de Medicina de Coimbra. Because of this, no additional security was added 
on the system firewall. However, if the system does not have a shared firewall, iptables 
should be used in order to optimize the Ubuntu firewall. iptables is a command-line 
packet filter utility that uses policy chains to allow or block traffic. When a system tries 
a connection with an Ubuntu system, iptables looks for a rule in its list to match it to. If 
it does not find one specific rule for that connection, the default rule is used. With 
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iptables it is possible, for example, to reject the communication of a certain IP with an 
Ubuntu system.16 
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5. Results and Discussion 
 
 In this section, a set of screenshots about the developed solution is shown 
together with a brief discussion of each one. At the end, a set of graphics is presented 
that will give a brief overview of the CNVs information already existing in the database. 
 
5.1. Log in and Sign in 
 
 When a user accesses the Array CGH DB, the Home page of the application 
(Figure 16) is shown. There he will be able to sign up if he is a new user or to log in if he 
is already registered. When a user select “Sign up”, a form is displayed which asks for 
some user information, such as first name, last name and an email, a username and a 
password which will be used to log in the user, a role (Researcher or Administrator) and 
the laboratory where the user is affiliated (Figure 17). 
 
 
Figure 16 – Home page of Array CGH DB. A user can choose: Log in, if he is already registered, or Sign up, for a new 
user registration. 
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Figure 17 – Sign up page of Array CGH DB. In order to “Sign up” a user has to fill some information about himself, 
choose a username, a password, a role and the affiliation laboratory. 
 
 After “Sign up”, a new user has to be confirmed by a Super-Administrator or by 
an Administrator from the same laboratory in order be able to log in (Figure 18). After 
being confirmed, when a user selects “Log in”, he is asked about a username and a 
password. For a successful “Log in”, this two have to be recognized (the same as chosen 
when he signed up). (Figure 19) 
 When a user “Logs in”, Session and Cookies variables are set. This process allows 
to control and make sure that users will only get access to functionalities and 
information according to their identification (Role, Laboratory, User ID). 
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Figure 18 – Successful “Sing up” message.  
 
 
Figure 19 – Log in page of Array CGH DB. In order to “Log in”, a user has to insert a username and a password that 
match.  
 
5.2. Users Navigation Bar 
 
 After “Log in”, a user will be redirected to the Home page. There he will see a 
Navigation Bar which allows him to access several functionalities according to his role. 
A Researcher is able to select “Clinic Case” to add new Clinic Cases or to manage Clinic 
Cases, or “CNV” to perform a CNV matching (Figure 20). An Administrator can select 
“User” to manage users, “Clinic Case” to manage Clinic Cases and “CNV” to perform a 
CNV matching (Figure 21). A Super-Administrator is able to select “Laboratory” to add 
new laboratories, “User” to manage users, “Clinic Case” to manage clinic cases and 
“CNV” to execute a CNV matching (Figure 22). 
 Although some Navigation Bar options have the same name for different roles 
its functionally can be different for each role. For Researchers and Administrators, 
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“CNV” allows a CNV matching with CNVs with public or hidden state linked to their 
laboratory, and with CNVs with public state linked to a different laboratory. For Super-
Administrator “CNV” permits a CNV matching with all CNVs recorded on database. For 
“User”, a Super-Administrator is able to approve or block the access to the software of 
any Researcher or Administrator registered on the database, but an Administrator is 
only authorized to approve or block the access of Researchers from the same laboratory 
as his. When accessing “Clinic Case”, a Super-Administrator can manage all clinic cases 
recorded on database, an Administrator is able to perform modifications on clinic cases 
linked to his laboratory and a Researcher can only manage clinic cases added by him. 
 “Home” and “Log out” are two functionalities available and with the same effect 
to any logged in user. “Home” redirects users to his Home page and “Log out” take users 
out of Array CGH DB by removing Session and Cookies variables defined when logged in. 
 
 
Figure 20 –Researcher: Home page and Navigation Bar. The Navigation Bar allows to select “Home”, “Clinic Case”, 
“CNV” or “Log out”. “Home” redirects a Researcher to this page, “Clinic Case” allows him add and manage clinic cases 
added by him, “CNV” is for matching CNVs and “Log out” to quit from Array CGH DB. 
 
 
Figure 21 – Administrator: Home page and Navigation Bar. The Navigation Bar allows to select “Home”, “User”, “Clinic 
Case”, “CNV” or “Log Out”. “Home” redirects an Administrator to this page, “User” is to manage users linked to his 
laboratory, “Clinic Case” allows manage clinic cases linked to his laboratory, “CNV” is for matching CNVs and “Log 
out” to quit from Array CGH DB. 
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Figure 22 –Super-Administrator: Home page and Navigation Bar. The Navigation Bar allows to select “Home”, 
“Laboratory”, “User”, “Clinic Case”, “CNV” or “Log Out”. “Home“ redirects a Super-Administrator to this page, 
“Laboratory” lets a Super-Administrator to manage and create new laboratories, “User” allows to manage 
Administrators and Researchers, “Clinic Case” allows him to manage all clinic cases, “CNV” is for matching CNVs and 
“Log out” to quit from Array CGH DB. 
 
5.3. Software Main Features 
 
 There are two main features in the software. The first allows the upload of new 
clinic cases to be stored in the database, and the second the query of the database about 
a CNV match. The query results are presented in a way that makes it easy to be 
interpreted by clinicians. 
 
5.3.1. Upload of Clinic Cases 
 
 The upload of Clinic Cases can be done by submitting a form where a Researcher 
has to specify the Clinic Cases format, and by uploading a .zip file with a set of 
spreadsheets (.xls) containing information about arrayCGH reports. There are two 
possible choices of format for arrayCGH reports: “IntervalBasedReport” and 
“TabelaClasses”. Those formats are used and known at Laboratório de Citogenética e 
Genómica da Faculdade de Medicina de Coimbra. The “TabelaClasses” is a handmade 
report which is delivered to clinicians and the “IntervalBasedReport” is a report exported 
by CytoGenomics, a software for CNV analyses. 
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Figure 23 - Researcher: Upload Clinic Case page. On this example is submitted a .zip file with “IntervalBasedReport” 
format. 
 
 Those two formats do not provide all the information about CNV and Genes 
needed in the database. The “TabelaClasses” format does not provide information 
about the genes contained on a certain CNV and the “IntervalBasedReport” format does 
not have the “type” field for CNVs. 
 If a set of arrayCGH results is uploaded in the “TabelaClasses” format, the “gene” 
field is not there and reports are uploaded without this information. For 
“IntervalBasedReport” format there are two ways for get the “type” field information: 
 
1. Researchers can introduce a column on the “IntervalBasedReport” spreadsheet 
with the “type” information. 
2. Researchers can provide the spreadsheets of “TabelaClasses” and 
“IntervaleBasedReport” on the same .xls file. The software will detect the missing 
field on “IntervalBasedReport” and will try a match between those two 
spreadsheets in order to get the “type” information for each CNV on the 
“IntervalBasedReport”. 
 
 After an upload of a .zip file, for each .xls file in the set, the software tries to read 
it, and looks for a spreadsheet with the name of the format indicated. This is performed 
with PHPExcel, an open source set of classes for the PHP programming language, which 
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allows to write to and to read from different spreadsheet formats. Then it verifies if all 
the fields required are present and if every CNV record has all the fields filled. 
 Subsequently, a validation process is performed which verifies if the uploaded 
data have the expected format. If one file fails, the corresponding Clinic Case is not 
stored and the software continues with the next .xls file. In the end, the user gets a 
report of the upload process, i. e. successfully stored Clinic Cases or errors that occurred 
during the process are displayed. The errors displayed are descriptive in order to help 
Researchers to fix them for a successful re-upload. 
 
 
Figure 24 – Researcher: Upload Report of Clinic Cases. On the report is showed information about the upload of two 
clinic cases, S6515M and S103814M. The first one, is not recorded on DB because it hasn’t the “classification” field for 
CNVs. S103814M passes on validation and is successfully added to DB. 
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Figure 25 Researcher: Upload Report of Clinic Cases. In this example, the clinic case S6515M was successfully recorded 
after being added the “classification” field. The clinic case S103814 already exists on DB and wasn’t re-added. 
 
 For uploaded .zip files there is a maximum file size of 5Mb, and after the 
information storage the uploaded files are deleted. The objectives are not to overload 
the server memory and to keep the hard disk storage free of unwanted files. 
 
5.3.2. Display CNV matching 
 
 The CNV matching is performed by sending a form with the information of a 
chromosome location or a gene name. After that, the software queries the database 
with the user request settings and builds a graph bar with the query results. Each bar of 
the graph represents a CNV matching the user request, in a way that all CNVs are 
horizontally aligned, taking as reference the request settings from the user, and the CNV 
attributes for start, stop and size. (Figure 26) 
 The bars have colours, each colour representing the CNV alteration type: red for 
deletion, blue for duplication, black for variations and brown for unknown. When placing 
the mouse over a CNV, the attributes start, stop and the alteration type are displayed 
(Figures 26 and 27). 
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Figure 26 – Researcher: CNV match with chromosome location. It is asked for a CNV matching for chromosome X with 
positions starting on 781817(bp) and stopping on 819243(bp). Results show the User Track bar and the CNVs that 
match the User Track. CNVs larger than the User Track are represented with white dots in the end. 
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Figure 27 - Researcher: CNV match with gene name. It is asked for a CNV matching for the gene CLCNKA. Results 
showed the User Track bar, the biggest CNV size in the database linked to CLCKA gene. All the other CNVs linked to 
the same gene are showed horizontally aligned with the User Track. 
 
 Each CNV is also available for a new CNV matching with the laboratory records 
or with the records on the UCSC Genome Database, a database with a large record 
collection of CNVs. If a user selects a CNV matching with the records of the UCSC 
Genome Database (https://genome.ucsc.edu), he will be redirected to the UCSC site and 
will get a CNV matching according to his request. This is a very simple process but very 
useful for clinicians, performed by passing the information of the selected chromosome 
location via URL (Uniform Resource Locator) for a CNV matching on UCSC Genome 
Database. Another important aspect about this functionality is the capacity of arrayCGH 
to communicate with other well stablished solutions in the assessment of pathogenicity 
of CNVs. 
 To draw bars, a graphical library called GD (Graphics Draw) is used, which allows 
PHP scripts to dynamically generate images in popular web formats, such as GIF, JPEG, 
and PNG, and either return them to the web browser for display or write them to a file 
on the server. 
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5.4. Other Features 
 
 Besides the upload of Clinic Cases and the display of CNV matches, the arrayCGH 
DB allows the management of Clinic Cases for Researchers, Administrators and Super-
Administrators, management of Users by Administrators and Super-Administrators and 
management of Laboratories by Super-Administrator. In the next section these 
functionalities are presented in detail. 
 
5.4.1. Management of Clinic Cases 
 
 Researchers, Administrators and Super-Administrators are able to manage Clinic 
Cases. However this management is different according to each role, as defined in the 
Software Requirements section. 
 When accessing to “Clinic Case” through the Navigation Bar, the available Clinic 
Cases are shown according to the user role, laboratory and ID. The Researcher can select 
view, edit or remove Clinic Cases added by him (Figure 28), the Administrator is able to 
view, remove or change the state, to be hidden or public, of Clinic Cases which are linked 
to his laboratory, and the Super-Administrator is able to perform the same tasks of an 
Administrator but for all Clinic Cases on the DB (Figure 29). On this page all users are 
able to sort Clinic Cases by Case Name, Gender, State or Join Date, and to search by Case 
Name, providing them an easy mechanism to find the information they need (Figure 30). 
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Figure 28 – Researcher: Clinic Case page. Clinic Cases added by a Researcher are shown on this page and he is able to 
select one of them to view, edit or remove. A Researcher is also able to sort the displayed information by Case Name, 
Gender, State or Join Date, and to perform a search by Case Name. 
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Figure 29 – Super-Administrator: Clinic Case page. All Clinic Cases added are shown on this page and Super 
Administrator is able to select one of them to view, change state or remove. A Super Administrator is also able to sort 
the displayed information by Laboratory, Researcher, Case Name, Gender, State or Join Date, and to perform a search 
by Case Name. 
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Figure 30 – Super Administrator: Clinic Cases sorted by genre. 
 
 By select “Edit” on Clinic Case page, a Researcher is able to update the 
information of the Clinic Case selected (Figure 31). 
 
 
Figure 31 – Researcher: Edit Clinic Case page. The Case Name, Gender and Comment of a certain Clinic Case are 
eligible to be edited by Researchers. 
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 When the option “View” is selected for a certain Clinic Case, the information 
linked to this case is shown, such as Case Name, Gender, State, Laboratory (name and 
email), the Researcher linked to the Clinic Case and his email, any Comment and all CNVs 
of the Clinic Case. Any CNV displayed on this page is available for a CNV match with the 
arrayCGH DB or UCSC data, and can be examined on section 5.3.2 Display CNV matching. 
If a user clicks on a gene name, he will be redirected to GeneCards Human Gene 
Database (http://www.genecards.org), in order to get more information about the gene 
selected. Through this page, the Researcher is able to edit CNVs if the Clinic Case is linked 
to him. (Figures 32 and 33) 
 
 
Figure 32 – Researcher: View Clinic Case page. All the Clinic Case information is shown, including the information of 
the CNVs linked to the case. If the Clinic Case is linked to the Researcher, any CNV showed can be edited. All users are 
able to use “Show CNV match” or “Show in UCSC” and by clicking on a gene name more information about that gene 
will be provided on Gene Cards Human Gene Database (http://www.genecards.org). 
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Figure 33 – Researcher: Edit CNV page. Researcher is capable to edit CNV information, such as Chromosome, 
Cytoband, Start, Stop, Genes, Inheritance, Type, Class and Comment, of Clinic Cases linked to him. 
 
 When a user selects “Remove” from the “Clinic Case” page, he is informed of the 
information he is about to delete and has to confirm by selecting “Yes” and then 
“Remove Clinic Case” in order to remove the Clinic Case (Figure 34). 
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Figure 34 – Researcher: Remove Clinic Case page. All information about to be deleted is shown, and in order remove 
the Clinic Case, users have to confirm by selecting “Yes” and then “Remove Clinic Case”. 
 
5.4.2. Management of Users 
 
 Super-Administrators and Administrators are able to manage users by selecting 
“Users” in the Navigation Bar. Super-Administrators can view information about any 
user (Super-Administrators, Administrators and Researchers), such as Name, Username, 
Role, State, Laboratory, Email and Join Date, and are capable to remove or change the 
state, to block or approve, of any Researcher or Administrator (Figure 35). 
Administrators can perform the same tasks of Super-Administrators but only for 
Researchers linked to their laboratory (Figure 36). Super-Administrators or 
Administrators are also able to search any user by name or sort any information 
displayed (Figures 35 and 36). 
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Figure 35 – Super-Administrator: “User” management page. Name, Username, Role, State, Laboratory, Email and Join 
Date of all users are shown, and any Researcher or Administrator can be removed or have his state set to Blocked or 
Approved by a Super-Administrator. A Super-Administrator is also able to search any user by Name or sort any 
information shown. 
 
 
Figure 36 - Administrator: “User” management page. Name, Username, Role, State, Laboratory, Email and Join Date 
of all users are shown, and any Researcher can be removed or have his state set to Blocked or Approved by an 
Administrator of the same laboratory. Administrators are also able to search any user by Name or sort any information 
shown. 
 
 When a user is selected for removal, a page with all the information about to be 
removed is shown and in order to delete it, the Administrator or Super-Administrator, 
need to confirm the operation by selecting “Yes” and then “Remove”. If the user 
selected for removal is a Researcher, all Clinic Cases linked to him will be removed, too. 
(Figure 37) 
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Figure 37 – Super-Administrator: Remove User page. All information about the user about to be removed is shown 
and if he was linked to clinic cases, they will be removed, too. 
 
 To change a user state, Super-Administrators or Administrator have to select the 
user through the “User” option on Navigation Bar and then choose “Change State”. After 
that, a message is shown and the user state is altered. (Figures 38 and 39) 
 
 
Figure 38 Super-Administrator: Message displayed when changing a user from blocked to approved. The state of user 
Maria Oliveira is changed to approved. 
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Figure 39 – Super-Administrator: User approved. On Figure 35, user Maria Oliveira is blocked, but after applying the 
“Change State” option her state is changed to approved. 
 
 If Super-Administrators or Administrators try to “Remove” or “Change State” of 
a user they are not allowed to, a message is shown and the action is not performed 
(Figure 40). 
 
 
Figure 40 – Administrator: Message shown when an Administrator tries to remove a user he has not permission to. 
Although an administrator is able to view a Super-Administrator (Figure 36), he is not able of remove him. 
 
 
5.4.3 Management of Laboratories 
 
 Super-Administrators are able to add new laboratories and remove or edit the 
existing laboratories through the “Laboratory” option on the Navigation Bar. When this 
option is selected, all information about the registered laboratories is shown (Name, 
Email, Contact, and Join Date). Super-Administrators are also able of sort the 
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laboratories by any of attribute shown or search a laboratory by its Name. (Figures 41, 
42 and 43) 
 
 
Figure 41 – Super-Administrator: Laboratory Management page. All information about the registered laboratories is 
shown (Name, Email, Contact, and Join Date). Super-Administrator is able to remove or edit any laboratory shown, or 
add a new one. He is also able to sort the laboratories by any of the attributes shown or search a laboratory by its 
Name. 
 
 
Figure 42 – Super-Administrator: Remove Laboratory page. Is shown all information of the laboratory, and all users 
and the number of Clinic Cases linked to the laboratory about to be removed. 
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Figure 43 – Super-Administrator: Edit Laboratory page. Here, Name, Email and Contact of a laboratory can be 
changed. 
 
5.5. Validation 
 
 In order to perform a validation for the arrayCGH DB, 529 Clinic Cases with 
several CNV records from Laboratório de Citogenética e Genómica da Faculdade de 
Medicina de Coimbra were uploaded using the “Upload of Clinic Cases”. After that, some 
queries were performed to report about the information stored in the database. At this 
moment, arrayCGH DB has 3254 CNV records. Below is given information about size, 
alteration type, classification and chromosomes of the 3240 CNV records stored. CNV 
records with wrong information, bugs, without class or alteration type will be discussed 
on section 6. Bugs Detected and Fixed.  
 
5.5.1 Distribution of CNVs by size 
 
Figure 44 report about the distribution of CNV sizes in the arrayCGH DB. 
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Figure 44 - CNVs Size Overview. Distribution of CNV size in the arrayCGH DB. 
 
5. Results and Discussion 
66 
 
5.5.2. Distribution of CNVs by alteration type type 
 
Figure 45 shows the distribution by alteration type of CNVs in the arrayCGH DB. 
 
 
Figure 45 - CNVs stored in the arrayCGH DB alteration type overview. 
 
5.5.3. Distribution of CNVs alteration type by size 
 
Figure 46 shows the distribution of CNVs alteration type by size. 
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Figure 46 –Distribution of CNVs alteration Type by CNV size. Percentages are related to the number of CNVs shown 
in Figure 44 for each size interval. 
 
5.5.4. Distribution of CNVs per chromosome and Distribution of CNVs alteration type per 
chromosome 
 
Figure 47 shows the number of CNVs per chromosome and Figure 48 the distribution of 
CNVs alteration type per chromosome in arrayCGH DB. 
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Figure 47 - Distribution of CNVs per Chromosome. 
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Figure 48 – Distribution of CNVs alteration type per chromosome in arrayCGH DB. Percentages are related to the 
number of CNVs shown in Figure 47 for each chromosome.  
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5.5.5. Distribution of CNVs class 
 
 Figure 49 shows the distribution of CNVs class. 
 
 
Figure 49 – Distribution of CNVs by class. 
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5.5.6. Distribution of CNVs class by size 
 
 Figure 50 shows the distribution of CNVs class by size. 
 
 
Figure 50 – Distribution of CNVs Class by size. 
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6. ArrayCGH DB Fixes 
 
 During validation and through some queries on the database, it was observed 
that some CNVs had wrong data, such as negative size, wrong class or alteration type. 
To fix them, clinic cases of CNVs with wrong data were identified in order to be able 
analyse the spreadsheets where they came from. After discovering what kind of issues 
were causing the wrong data, minor changes on arrayCGH DB were performed, wrong 
data was edited or deleted and re-uploaded. 
 
6.1. Negative Size Fix 
 
 Nine CNVs with negative size were identified. This problem was caused when 
Clinic Cases with “Tabela Classes” format were uploaded with CNV Start greater than 
Stop. Now, when the upload of Clinic Cases is performed, it is checked if they have CNVs 
with Start greater than Stop, and if they have they are not stored on database, and 
Researchers are informed that the clinic case has wrong Start or Stop, causing negative 
size (Figure 51). The nine CNVs with negative size were fixed using the option edit CNV 
of arrayCGH DB after consulting the respective “IntervalBasedReport” spreadsheets, 
where the values were correct (Figures 52, 53, and 54). 
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Figure 51 – Upload report of a Clinic Case with one CNV where Start is greater than Stop. 
 
 
Figure 52 – Clinic Case where one CNV has a Start greater than Stop and consequently has negative size. 
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Figure 53 – Editing of Stop from the wrong CNV of Figure 52, after consulting the respective “IntervalBasedReport” 
where the values were correct. 
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Figure 54 – Clinic Case of Figure 52 after being edited. 
 
6.2. Class Fix 
 
 Seven CNVs were identified where class was misspelled, caused in Clinic Cases 
with “Tabela Classes” format upload, and five CNVs where the class is uncertain on the 
spreadsheets (double classification with question mark). In order to fix these problems 
during the upload of Clinic Cases, it is now verified if CNVs class matches the known 
types (“I”, “II”, “IIIA”, “IIIB” and “IV”) and if not, the clinic case with wrong class is not 
stored in the database and Researchers are informed that the clinic case has wrong 
class(es). (Figures 55, 56 and 57) 
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Figure 55 – Clinic Case with several CNVs with wrong class (sup). 
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Figure 56 – 4 CNVs with wrong class (IIB) caused by a misspelling on the uploaded spreadsheet. 
 
 
Figure 57 – Two Clinic Cases with wrong class which are not stored on ArrayCGH DB. 
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6.3. Alteration Type Fix 
 
 Fifty five CNVs were identified where the alteration type was “unknown”, which 
happened when Clinic Cases with “Tabela Classes” format were upload with misspelling 
on the alteration type, and three CNVs had an alteration type of “Triplicação”, which is 
a region not described on Table V. In order to fix these problems, now, when uploading 
Clinic Cases performed, it is verified if CNVs alteration type matches the known types 
(“Deleção”, “Duplicação”, “Amplificação”, “Triplicação” and “Variação”) and if not, the 
clinic case with wrong type is not stored in the database and Researchers are informed 
that the clinic case has wrong alteration type(s). The new alteration type, Triplication, 
was added and it is now recognized in all pages of arrayCGH DB (Figures 58 and 59). 
 
 
Figure 58 – Clinic Case with one CNV where the alteration type is Triplication. 
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Figure 59 – CNV match where one CNV with alteration type of Triplication appears. 
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7. Overview, Conclusions and Future Perspectives 
 
7.1. Overview 
 
 Microarray Comparative Genomic Hybridization (arrayCGH) allowed a significant 
advance on the diagnose of unexplained development diseases by detecting genomic 
copy number variations (CNVs) that were previously undetectable by other types of 
cytogenetic technologies. In order to determine if a CNV is pathogenic or not, it was 
necessary compare a CNV with other CNVs already classified as benign or pathogenic, 
which is performed, in most of the cases, by querying a database with CNVs records 
already analysed and classified. (Section 2. Background) 
 At Laboratório de Citogenética e Genómica da Faculdade de Medicina de 
Coimbra are performed per year about 1000 arrayCGH tests and results are stored in 
spreadsheets. This kind of management of arrayCGH results do not provide an easy way 
to find the results they need to help in the decision about the pathogenicity of recent 
CNVs. This situation prompted them to look into a more efficient way to save and query 
their results, so they decided to request the development of an in-house relational 
Database (DB) to store their results and an application which allows them to feed and 
query the DB. (Section 2. Background) 
 Although researchers were aware that they need a database, they did not have 
more defined than the original request: “Develop and implement a relational database 
which should contain arrayCGH results from patients with cognitive deficit, and also to 
allow a set of queries defined by the laboratory clinicians in a way that can answer to 
questions or hypotheses related with new arrayCGH results”. So it was necessary to start 
a software development process. First, a set of software requirements was defined, 
using different techniques such as brainstorming, role playing and observation, which 
allowed to identify the real requirements and to add functionalities to the software that 
were not in the original first request. (Section 3.1. Software Requirements) 
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 Afterwards, with the more complete requirements information, Use Case 
Diagrams (UCD) were defined in order to model the dynamic behaviour of the system 
and were developed an Entity-Relationship Model (ERM) and a Relational Model (RM), 
which helped to set tables, columns, columns data types and to map the relations 
between the tables. This allowed to construct a relational database to store all the 
information the software needed to fulfil the requirements. (Section 3.2. Software 
Design) 
 When the software design was finished, a LAMP (Linux, Apache, MySQL and PHP) 
server was set up which allows to analyse requests, store information and deliver 
responses according to the requests. This solution was chosen because it is a well-known 
and robust solution, and in addition, has the advantage of being freely available (open 
source). MySQL was used to create the tables and the relations, defined on RM, to store 
the information the software need to work, and PHP to create the scripts which make it 
possible to perform the functionalities defined through the requirements. Apache was 
responsible for receiving and delivering user requests. (Section 3.3. Server: LAMP 
technology) 
 Security was a requirement considered in all stages of Software Development. 
The access to data stored in the database is regulated by user-level permissions, and all 
information requests through arrayCGH DB are analysed to determine if the user has 
permission to access the information he is asking for. Deletes are on cascade, which is 
crucial to safeguard the data referential integrity and will prevent errors related to this 
subject. Some precautions were taken in order to avoid SQL injection; data validation 
processes are used through PHP functions and PHP MySQL functions in order to inhibit 
this kind of database attacks. By backing up the database daily it is possible to restore 
all the information stored in case of any system crash or corruption. (Section 4. Security) 
 After the software development, the database was populated with 3254 CNVs 
records from several Clinic Cases, uploaded through the Upload of Clinic Cases feature, 
which was developed with the propose of analysing spreadsheets with CNV information, 
and thus storing them in the ArrayCGH DB. Next, in order to know about the CNV data 
stored, several queries were made on the CNVs stored in database. This process allows 
to analyse the distribution of CNVs for several CNV attributes, such as alteration type, 
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size, class and chromosome, and in addition, it helps to identify some problems with the 
uploaded information. The identified problems were analysed and to fix them, some 
adjustments in the ArrayCGH DB were made. (Section 5. Results and Discussion and 
Section 6. ArrayCGH DB Fixes) 
 
7.2. Conclusions and Future Perspectives 
 
 The arrayCGH DB provides an efficient way for uploading spreadsheets of 
arrayCGH results performed at Laboratório de Citogenética e Genómica da Faculdade de 
Medicina de Coimbra, and also performing queries of previously analysed CNVs, through 
a CNV matching executed with CNVs from arrayCGH DB and/or UCSC Genome Browser. 
Furthermore, the arrayCGH DB allows Researchers to keep track and edit their arrayCGH 
results and Administrators to share arrayCGH results with other laboratories and 
consequently with other Researchers. This makes arrayCGH DB a valuable tool in daily 
clinical diagnose for laboratories and clinicians using this technique. The data stored 
about CNVs could also be a starting point for new studies related with human 
unexplained development diseases that could bring new discoveries in this field. 
 In case a new laboratory requests the use of arrayCGH DB, it is necessary to 
analyse the arrayCGH reports of that laboratory in order to know if they fit in the upload 
formats available (“IntervalBasedReport” or “TabelaClasses”) and in the database model 
developed. If not, in the developed solution, it is possible to add a new format, reusing 
all the work done, and to upload the arrayCGH results from the new laboratory into the 
arrayCGH DB. 
 The greatest difficulty identified when developing this work was to gather the 
software requirements because laboratory researchers are not familiar with informatics 
terminology and this made difficult the discussion about some 
functionalities/behaviours of the software. In order to solve this problem were 
developed in a first step and shown some software functionalities to the researchers, 
which allowed them to visualize and understand some concepts difficult to explain, and 
thus get their feddback. 
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 Although all the goals of the project have been accomplished with the ArrayCGH 
DB solution, it is possible to do more and better in future by code refactoring, improving 
or adding new functionalities and by giving to the ArrayCGH DB a better visual 
presentation. Shortly, code refactoring will allow to have a more robust code without 
any changes on the present functionalities, but will improve the code design making 
even easier to add new functionalities and manage the arrayCGH DB. There are a many 
new functionalities possible to add, for example, put a spreadsheet on the Clinic Case 
View page allowing Researchers to edit multiple CNVs of the same Clinic Case at the 
same time, create an export or print option for Clinic Cases providing a tool for 
Researchers to deliver arrayCGH reports through the arrayCGH DB, develop a more 
attractive and informative home page with some information about the project and with 
some CNV overview graphs, as the graphs used at section 5.5. Validation. However, the 
main task at this moment should be to populate the database with the Clinic Cases that 
are not yet uploaded, about 2500 Clinic Cases, obtain and analyse the users’ feedback, 
and then discuss the future of the arrayCGH DB. 
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